Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disorder closely linked to metabolic syndrome. Identifying novel, easily measurable biomarkers could significantly enhance the diagnosis and management of NAFLD in clinical settings. Recent studies suggest that immunoinflammatory biomarkers—specifically, the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR)—may offer diagnostic value for NAFLD. However, the effectiveness of these biomarkers has not been comprehensively assessed in this patient population. This systematic review and meta-analysis aimed to evaluate the association between these immunoinflammatory biomarkers and NAFLD. As of August 8, 2024, databases including PubMed, EMBASE, Cochrane Library, Web of Science, and Scopus were systematically searched to compare NLR, PLR, and LMR levels in NAFLD patients and healthy controls. Study quality was assessed using the Newcastle–Ottawa Scale, and standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated (PROSPERO registry number: CRD42024580812). A total of 20 studies were included in the meta-analysis. Results indicated that NAFLD patients had significantly higher NLR levels (SMD = 0.43; 95% CI 0.28–0.58; p < 0.001) and lower PLR levels (SMD = − 0.29; 95% CI − 0.41 to − 0.17; p < 0.001) compared to controls. However, no significant difference in LMR was observed between NAFLD patients and controls(SMD = 0.08; 95% CI − 0.00 to 0.17; p = 0.051). These findings suggest that NLR and PLR may hold promise as diagnostic markers for NAFLD, while LMR appears to have limited diagnostic utility. Further research is warranted to explore the potential role of these biomarkers in tracking disease progression.
1 January 2026 in Translational Gastroenterology and Hepatology
Objective: This study aimed to compare the relative efficacy of dietary supplements and pharmacological agents in improving metabolic and oxidative stress outcomes in patients with metabolic dysfunction-associated fatty liver disease (MAFLD) through a systematic review and Bayesian network meta-analysis. Methods: PubMed, Embase, the Cochrane Library, and Web of Science databases were systematically searched to identify randomized controlled trials (RCTs) published between 1 January 2014, and 3 March 2024, that evaluated the effects of dietary supplements or pharmacological agents on MAFLD. Results: A total of 106 RCTs involving 7,273 participants were included, involving a variety of nutritional and pharmacological interventions. Pharmacological intervention plus bioactive regulator was the most effective in reducing triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C). Nutrient plus pharmacological intervention was the most efficacious in improving glycated hemoglobin (HbA1c) and insulin levels. Pharmacological intervention plus another pharmacological intervention was most effective in reducing alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Phytochemicals significantly reduced interleukin-6 (IL-6), while bioactive metabolic regulators markedly decreased tumor necrosis factor-α (TNF-α). Herbal extracts demonstrated superior effects in enhancing total antioxidant capacity (TAC) and superoxide dismutase (SOD), while oleoylethanolamide (OEA) improved antioxidant enzyme activity and reduced malondialdehyde (MDA) levels. Further analysis revealed that garlic exerted the strongest effect in improving overall antioxidant capacity, whereas L-carnitine showed the most significant efficacy in suppressing lipid peroxidation. Conclusion: Multicomponent or mechanistically complementary interventions exhibited more stable potential benefits in improving glucose and lipid metabolism. Bioactive metabolic regulators (L-carnitine), endogenous lipid regulators (OEA), and herbal extracts (garlic) all demonstrated strong efficacy in enhancing antioxidant defense and alleviating oxidative damage. Further high-quality RCTs are needed to confirm these findings. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD42024555065.
5 September 2025 in International Journal of Surgery
Dietary habits play a crucial role in everyday health, influencing both the onset and progression of diseases. Previous studies have shown some effects of dietary habits on certain thyroid diseases. However, comprehensive research on the causal relationship between dietary habits and thyroid diseases is lacking. The purpose of this study was to investigate the potential causal relationship between 45 genetically predicted dietary intake habits and thyroid diseases. We obtained GWAS data for 45 dietary intake habits from the UK Biobank and for 10 thyroid diseases from the FinnGen R12 database. We performed univariable Mendelian randomization (UVMR) using the inverse variance weighted (IVW) test as the primary test and corrected the results by false discovery rate (FDR) analysis. Additionally, multivariable Mendelian randomization analysis (MVMR) was further applied to assess independent effects of dietary habits. Linkage disequilibrium score regression (LDSC) was conducted on the FDR‐corrected significant findings. UVMR identified 28 potential causal associations, of which six remained significant after FDR correction. Cheese intake and alcohol consumption during meals were suggestively associated with a lower risk of hypothyroidism. Poultry consumption showed a potential association with a higher risk of nontoxic thyroid nodules, while moderate red wine intake appeared to be linked with a lower risk. In MVMR analyses adjusting for conventional confounders, the association between poultry consumption and both nontoxic nodules and goiter remained suggestive of an independent effect. These findings suggest potential causal links between dietary factors and thyroid diseases; however, considering the MR assumptions and horizontal pleiotropy, these estimates should be interpreted with caution, as they are hypothesis‐generating rather than prescriptive for clinical nutrition.
23 August 2024 in Advances in Integrative Medicine